arXiv subjects

Samuel A. McLean

Publications and source records attributed to Samuel A. McLean.

3 recordsLinked to original sources

arXiv2026

Circadian Derived Features for Early Discrimination Across Insomnia Severity Levels: At Least 8 Weeks of Monitoring Are Needed for Clinically Meaningful Assessment

Background: Wearable devices provide continuous, objective measures of daily activity and offer promise for assessing sleep disorders. However, the minimum monitoring duration needed to differentiate insomnia severity remains unclear. We investigated when wearable-derived behavioral features become informative for distinguishing Insomnia Severity Index (ISI) categories and examined the contribution of Activity Count (AC) and circadian-derived features. Methods: We analyzed wearable data from 2,305 participants in the Advancing Understanding of Recovery after Trauma (AURORA) study. Separate binary classifiers were developed for four ISI categories across six follow-up periods using AC and circadian-derived feature sets. Performance was evaluated using accuracy, F1-score, precision, recall, and AUROC. Results: Classification improved with longer monitoring. Across ISI categories, approximately eight weeks was the earliest time point at which wearable-derived features consistently achieved informative discrimination, with modest improvements thereafter. Participants without clinically significant insomnia were easiest to identify, reaching an AUROC of 0.693. Circadian-derived features performed comparably to, and in several cases better than, AC features, suggesting that the temporal organization of daily activity provides information beyond overall activity volume. Conclusions: Approximately eight weeks of longitudinal wearable monitoring may represent a practical minimum for differentiating ISI-defined insomnia categories. Longer monitoring provided only incremental improvements. Circadian behavioral features show promise as digital biomarkers for objective insomnia assessment.

q-bio.QM↗

arXiv2025

Statistical Design and Rationale of the Biomarkers for Evaluating Spine Treatments (BEST) Trial

Chronic low back pain (cLBP) is a prevalent condition with profound impacts on functioning and quality of life. While multiple evidence-based treatments exist, they all have modest average treatment effects$\unicode{x2013}$potentially due to individual variation in treatment response and the diverse etiologies of cLBP. This multi-site sequential, multiple-assignment randomized trial (SMART) investigated four treatment modalities with two stages of randomization and aimed to enroll 630 protocol completers. The primary objective was to develop a precision medicine approach by estimating optimal treatment or treatment combinations based on patient characteristics and initial treatment response. The analysis strategy focuses on estimating interpretable dynamic treatment regimes and identifying subgroups most responsive to specific interventions. Broad eligibility criteria were implemented to enhance generalizability and recruitment, most notably that participants could be eligible to enroll even if they could not be assigned to one (but no more) of the study interventions. Enrolling participants with restrictions on the treatment they could be assigned necessitated modifications to standard minimization methods for balancing covariates. The BEST trial represents one of the largest SMARTs focused on clinical decision-making to date and the largest in cLBP. By collecting an extensive array of biomarker and phenotypic measures, this trial may identify potential treatment mechanisms and establish a more evidence-based approach to individualizing cLBP treatment in clinical practice.

stat.AP↗

arXiv2020

Using Convolutional Variational Autoencoders to Predict Post-Trauma Health Outcomes from Actigraphy Data

Depression and post-traumatic stress disorder (PTSD) are psychiatric conditions commonly associated with experiencing a traumatic event. Estimating mental health status through non-invasive techniques such as activity-based algorithms can help to identify successful early interventions. In this work, we used locomotor activity captured from 1113 individuals who wore a research grade smartwatch post-trauma. A convolutional variational autoencoder (VAE) architecture was used for unsupervised feature extraction from four weeks of actigraphy data. By using VAE latent variables and the participant's pre-trauma physical health status as features, a logistic regression classifier achieved an area under the receiver operating characteristic curve (AUC) of 0.64 to estimate mental health outcomes. The results indicate that the VAE model is a promising approach for actigraphy data analysis for mental health outcomes in long-term studies.

cs.LG↗